FACTS ABOUT MILD COGNITIVE IMPAIRMENT TREATMENT REVEALED

Mainly because people that have the APOE e4 gene variant seem to possess a better hazard of significant complications, the FDA recommends getting tested to the gene variant before beginning treatment with lecanemab or donanemab.Head injuries and an infection on the Mind or even the masking of the brain and spinal wire (meninges) could cause cogniti